NMTC - NeuroOne Medical Technologies Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
41.25M
Enterprise Value 3
38.28M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-6.47

Trading Information

Stock Price History

Beta (3Y Monthly) 0.47
52-Week Change 3-50.63%
S&P500 52-Week Change 315.46%
52 Week High 39.8900
52 Week Low 31.2100
50-Day Moving Average 32.2054
200-Day Moving Average 32.7816

Share Statistics

Avg Vol (3 month) 312.84k
Avg Vol (10 day) 360.57k
Shares Outstanding 513.49M
Float 7.39M
% Held by Insiders 166.59%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2110/100
Last Split Date 3Mar 18, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -5.91M
Net Income Avi to Common (ttm)-8.03M
Diluted EPS (ttm)-0.7310
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.25M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.72
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-5.33M
Levered Free Cash Flow (ttm)N/A